Purpose of the Test
- Assess the likelihood of ovarian cancer in women with a pelvic mass.
- Differentiate between benign and malignant tumors with high sensitivity.
- Assist in referring patients to specialized gynecologic oncology teams.
Book ROMA Index Test in Saudi Arabia | Lahalak Medical Platform
The ROMA Index is an advanced assessment combining HE4 and CA-125 levels with menopausal status to accurately estimate the risk of ovarian malignancy, ensuring timely diagnosis and intervention.
Scientific name: Risk of Ovarian Malignancy Algorithm (ROMA Index)
A laboratory test measuring HE4 and CA-125 to estimate ovarian cancer risk. It provides superior accuracy compared to single markers for assessing pelvic masses in pre and postmenopausal women.
Service type
Laboratory test
Duration
15-20 minutes
Fasting
Fasting is not required
Included Services
- Human Epididymis Protein 4 (HE4) Test
- Cancer Antigen 125 (CA-125) Test
- ROMA Score Calculation
Medical Service Information
Who Should Get This Test?
- Women experiencing chronic pelvic pain or bloating.
- Patients with a pelvic mass identified via ultrasound or CT scan.
- Women with a strong family history of ovarian or breast cancer.
Advantages of ROMA Index
- Higher diagnostic accuracy compared to CA-125 alone.
- Fewer false positives in cases of endometriosis.
- Tailored risk calculation based on menopausal status.
Conditions & Notices
- Menopausal status (pre or post) must be specified for accurate calculation
Medical services you might also like
